Phase I/II, Double-blind, Placebo-controlled, Multi-dose Escalation Trial of a Humanized Respiratory Syncytial Virus (RSV) Monoclonal Antibody (MEDI-493) in Children Hospitalized with RSV • 906 | Zendy

AI Assistant Blog Pricing

Phase I/II, Double-blind, Placebo-controlled, Multi-dose Escalation Trial of a Humanized Respiratory Syncytial Virus (RSV) Monoclonal Antibody (MEDI-493) in Children Hospitalized with RSV • 906

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.